On a disclosed annual basis, revenue fell from KRW 101.4 billion in 2022 to KRW 7.13 billion in 2023, down 93.0%, then recovered to KRW 10.1 billion in 2024, up 41.6%, before declining 6.7% to KRW 9.42 billion in 2025. Among 2022 to 2025, 2022 was the largest year and 2023 the smallest.
Operating profit of KRW 25 billion in 2022 (operating margin 24.6%) turned into an operating loss of KRW 22.8 billion in 2023, and the loss then narrowed to KRW 22 billion in 2024 and KRW 18.8 billion in 2025.
Losses have been recorded for three years running from 2023 to 2025, with operating margins of -319.1%, -218.1% and -199.9%.
Net income attributable to controlling shareholders moved from KRW 26.7 billion in 2022 to a loss of KRW 17.2 billion in 2023, a loss of KRW 15.2 billion in 2024, and a wider loss of KRW 23.3 billion in 2025.
Net loss including non-controlling interests, at KRW 23.5 billion in 2025, is a different figure from the controlling-shareholder result.
The 2022 revenue peak appears to have leaned on COVID-19 testing contracts, and a February 2022 disclosure of a KRW 22 billion self-test kit contract was reported as roughly 28% of the prior year's sales.
Operating cash flow went from KRW 30.4 billion in 2022 to KRW -12.2 billion in 2023, KRW -7.52 billion in 2024 and KRW -14.6 billion in 2025.
At the end of 2025, total equity was KRW 76.5 billion (KRW 76.3 billion attributable to controlling shareholders) and total liabilities were KRW 21.7 billion, with the debt ratio rising from 10.6% in 2024 to 28.3% in 2025.
Quarterly revenue went from KRW 1.48 billion in Q3 2025 and KRW 2.87 billion in Q4 2025 to KRW 2.35 billion in Q1 2026, then KRW 3.08 billion in Q2 and KRW 3.45 billion in Q3 2026, rising for two consecutive quarters.
Operating losses narrowed from KRW 4.84 billion in Q3 2025 and KRW 5.12 billion in Q4 2025 to KRW 4.68 billion, KRW 4.23 billion and KRW 3.29 billion across Q1 to Q3 2026.
The controlling-shareholder net loss, however, widened to KRW 4.19 billion in Q3 2026 from KRW 3.79 billion in Q2, and the four quarters from Q4 2025 to Q3 2026 total KRW 23.4 billion. Third-party compilation shows first-half 2026 revenue up 7.3% year on year, operating loss up 0.5% and net loss down 3.7%.